Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 25;56(10):e01108-18.
doi: 10.1128/JCM.01108-18. Print 2018 Oct.

Pulmonary Tuberculosis Conversion Documented by Microscopic Staining for Detection of Dynamic, Dormant, and Dead Mycobacteria (DDD Staining)

Affiliations

Pulmonary Tuberculosis Conversion Documented by Microscopic Staining for Detection of Dynamic, Dormant, and Dead Mycobacteria (DDD Staining)

A Loukil et al. J Clin Microbiol. .
No abstract available

Keywords: Mycobacterium tuberculosis; dormancy; fluorescence microscopy; pulmonary tuberculosis.

PubMed Disclaimer

Figures

FIG 1
FIG 1
DDD staining results after microscopic observation and counting. DAPI, FDA, and NR channels were used for the microscopic acquisition and image overlay. Image acquisition was performed with a Zeiss spinning-disk confocal microscope using a 63×, 1.4 numeric aperture (NA) oil immersion objective. (A) Comparison between the percentages of dynamic, dead, and dormant Mycobacterium tuberculosis mycobacteria in the sputum specimens collected before and after antituberculous treatment. **, P < 0.001 by Pearson's chi-square statistic test. (B) Fluorescence microscopy images of sputum smears collected before antituberculous treatment showing dynamic mycobacteria as FDA- and DAPI-positive bacilli (green arrows), dead mycobacteria as DAPI-positive and FDA-negative bacilli (blue arrow), and dormant mycobacterium as FDA- and DAPI-positive bacilli holding NR-positive intracellular inclusions (red arrow). (C) Fluorescence microscopy images of sputum smears from specimens collected before antituberculous treatment, showing dynamic mycobacteria as FDA- and DAPI-positive bacilli (green arrow) and a dormant mycobacterium as FDA-negative and DAPI-positive bacilli with NR-positive intracellular lipid bodies (red arrow). (D) Fluorescence microscopy images of sputum smears from specimens collected after antituberculous treatment, showing a dormant M. tuberculosis bacterium holding five NR-positive intracellular inclusions and a dormant M. tuberculosis bacterium measuring 4.4 μm and containing 2 lipid bodies.

References

    1. Datta S, Sherman JM, Tovar MA, Bravard MA, Valencia T, Montoya R, Quino W, D'Arcy N, Ramos ES, Gilman RH, Evans CA. 2017. Sputum microscopy with fluorescein diacetate predicts tuberculosis infectiousness. J Infect Dis 216:514–524. doi:10.1093/infdis/jix229. - DOI - PMC - PubMed
    1. Dietrich J, Roy S, Rosenkrands I, Lindenstrøm T, Filskov J, Rasmussen EM, Cassidy J, Andersen P. 2015. Differential influence of nutrient-starved Mycobacterium tuberculosis on adaptive immunity results in progressive tuberculosis disease and pathology. Infect Immun 83:4731–4739. doi:10.1128/IAI.01055-15. - DOI - PMC - PubMed
    1. Woolhiser L, Tamayo MH, Wang B, Gruppo V, Belisle JT, Lenaerts AJ, Basaraba RJ, Orme IM. 2007. In vivo adaptation of the Wayne model of latent tuberculosis. Infect Immun 75:2621–2625. doi:10.1128/IAI.00918-06. - DOI - PMC - PubMed
    1. Vilchèze C, Kremer L. 2017. Acid-fast positive and acid-fast negative Mycobacterium tuberculosis: the Koch paradox. Microbiol Spectr 5(2):TBTB2-0003-2015. doi:10.1128/microbiolspec.TBTB2-0003-2015. - DOI - PMC - PubMed
    1. Deb C, Lee C-M, Dubey VS, Daniel J, Abomoelak B, Sirakova TD, Pawar S, Rogers L, Kolattukudy PE. 2009. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One 4:e6077. doi:10.1371/journal.pone.0006077. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources